Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022) - Scorecard - MDSpire

Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022)

  • By

  • Robina Josiah Willock

  • Samah R. Nabi

  • Daniel C. Parks

  • Brye A. Qaseem

  • Miriam A. Miles

  • April 14, 2026

  • 0 min

Share

Clinical Scorecard: Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022)

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

                Original Source(s)

                Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022)

                • by Robina Josiah Willock, Samah R. Nabi, Daniel C. Parks, Brye A. Qaseem, Miriam A. Miles

                • April 14, 2026

                Related Content

                Clinical significance of lesion conspicuity on contrast-enhanced mammography

                Trastuzumab emtansine versus trastuzumab plus pertuzumab for HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world study

                Optimizing outcomes with less than more: multi-institutional experience of fast-forward fractionation and the impact of dosimetric parameters on toxicity in breast cancer patients